Document:

EX-10.26

 Exhibit 10.26 
  

 
  
 400
Somerset Corporate Blvd. 
 Bridgewater, NJ 08807 

www.valeant.com 
 July 1, 2015 

Mr. Brian Stolz 
 Dear Brian: 

This letter agreement outlines the details of your continuing employment with Valeant Pharmaceuticals International, Inc. (the “Company”), and your
Company assignment during the Employment Term (as defined below). 
  

	1.	Effect on Other Agreements. 

  

	 	(a)	Except as specifically described in Section 1(b) and referenced in Section 11(k), the terms of this letter agreement constitute the entire agreement between the Company and you with respect to the subject
matter hereof, and supersede all prior agreements and negotiations, including, without limitation, the terms of the letter agreement between you and the Company, dated June 27, 2011 (the “June 2011 Letter”). 

 

	 	(b)	For the avoidance of doubt, except as specifically set forth in Section 11(l) of this letter, the terms of any equity awards held by you with respect to the Company and those granted in conjunction with the
execution of this letter agreement shall continue to be governed exclusively by the terms set forth in the plan and award agreement governing each such award. 

  

	2.	Employment Term; Title: Duties. 

  

	 	(a)	Employment Term. Your employment term (the “Employment Term”) under this letter agreement shall be for the period commencing on the date hereof (the “Effective Date”) and ending on the date
that is forty-two months following the Effective Date, unless the Employment Term is terminated earlier pursuant to Section 6 hereof. For the avoidance of doubt, you shall not be entitled to payments pursuant to Section 8 of this letter
agreement upon the termination of your employment upon or following the expiration of the Employment Term. 

 Brian Stolz 
 Page 2

  

	 	(b)	Title. During the Employment Term, you shall serve as Senior Vice President – Neurology, Dentistry and Generics. You will report initially to the Company’s Chief Executive Officer and thereafter to the
Chief Executive Officer or such other person designated by the Company from time to time. It is contemplated that you shall be part of an extended executive management team or similar-level management group that the Company may establish (such
group, including any successor to such group, the “E-EMT”). Upon the commencement of the Employment Term, you shall no longer be a member of the most senior management group, the Executive Management Team (such group, and any successor
group, the “EMT”) or a Section 16 “executive officer” or other “executive officer” of the Company. The establishment of any E-EMT or similar management structure is under consideration and there is no guarantee
that any such group shall be established. Your principal place of employment will be in New Jersey. 

  

	 	(c)	At-Will Employment; Duties. Your employment with the Company is “at-will.” This means that you or the Company have the option to terminate your employment at any time, with or without advance notice,
and with or without cause. The at-will nature of your employment can be altered only by a written agreement specifying the altered status of your employment. Such written agreement must be signed by both you and the Chief Executive Officer. During
the Employment Term, you shall devote your full business time, energy and best efforts to the performance of your duties hereunder and shall not engage, directly or indirectly, in any other business, profession, occupation or investment, for
compensation or otherwise, which would conflict or interfere with the rendition of such services. 

  

	3.	Annual Compensation. 

  

	 	(a)	Base Salary. Your base salary during the Employment Term shall be $550,000 per year, and the Company, in its sole discretion, may increase such amount from time to time. 

 

	 	(b)	Annual Incentive. You will be eligible to participate in the Company’s management bonus plan as in effect from time to time for each calendar year during the Employment Term, with a target bonus of 80%, with
the potential of 160% of your base pay. The terms of any such plan will be determined in the discretion of the Company’s Board of Directors (the “Board”) (or a committee thereof), which will retain the discretion to amend or terminate
any such plan at any time in its sole discretion. Any annual incentive to which you become entitled shall be payable at the time management bonuses are paid generally. Except as otherwise set forth herein in Section 8, to be eligible for any
bonus payment, you must be employed by the Company, and not have given or received notice of the termination of your employment, on the day on which the applicable bonus is paid to other members of the Company management. 

 Brian Stolz 
 Page 3

  

	4.	Equity Awards; Equity Ownership; Matching Grants. 

  

	 	(a)	Equity Awards. As soon as practicable after the Effective Date, under the Company’s 2014 Omnibus Incentive Plan (the “Plan”), subject to any required approvals of the Board (or a committee
thereof), the Company will take such action as to grant to you 21,000 performance-based restricted share units (“PSUs”) under the Plan, pursuant to award agreements which shall contain the terms consistent with the customary terms of such
grant by the Company, including without limitation, (x) that such PSUs shall be measured approximately 3 years (or 4 years) from the PSU grant date and provide for 100-300% vesting based on 10%-30% annual compounded total shareholder return
growth rates (“TSR”) over the measurement periods, (y) that any acceleration due to TSR performance shall not occur prior to the second anniversary of the grant date and (z) in no circumstance shall any vesting above the 200%
level occur, nor any shares above the 200% level be deliverable, due to TSR performance until and unless you are employed with the Company and in good standing (including not having given or received any notice of termination of employment, by
either party and for any reason) on the third anniversary of the PSU grant date. 

  

	 	(b)	Share Ownership Commitment. You also agree to comply with any applicable share ownership requirements adopted by the Company, as may be amended from time to time, which shall require you to hold Company shares to
the extent that share ownership is required for similarly situated employees of the Company, which you acknowledge that, as a member of the E-EMT, is two times the sum of your base salary and annual bonus target. 

 

	 	(c)	Matching Grants for Share Purchases. In connection with such share ownership, you shall continue be eligible to receive matching share units to the extent such a program continues to be maintained by the Company
for similarly situated employees of the Company, in accordance with the terms of any such program as may be in effect from time to time. For avoidance of doubt, any prior purchases and matching under this program shall count toward the program
limits and nothing in this letter creates a new matching opportunity other than to the extent your matching limit is increased due to an increase in your previous base salary or target bonus. 

 

	5.	Benefits. 

  

	 	(a)	Business Expense Reimbursement. Upon submission of proper invoices in accordance with the Company’s normal procedures, you shall be entitled to receive prompt reimbursement of all reasonable out-of-pocket
business, entertainment and travel expenses incurred by you in connection with the performance of your duties hereunder. 

 Brian Stolz 
 Page 4

  

	6.	Termination. Your employment and the Employment Term may be terminated under the circumstances described in paragraphs (a)-(f) of this Section 6. The effective date of any such termination is
referred to herein as the “Termination Date.” 

  

	 	(a)	Death. Your employment shall be terminated as of the date of your death and your beneficiaries shall be entitled to the Accrued Obligations described in Section 7 hereof. 

 

	 	(b)	Disability. The Company may terminate your employment, on written notice to you after having established your Disability and while you remain Disabled, and you shall be entitled to the Accrued Obligations
described in Section 7 and any benefits to which you may be entitled under any applicable disability plan of the Company. For purposes of this letter, “Disability” shall have the meaning assigned to such term in the Plan.

  

	 	(c)	Without Cause. The Company may terminate your employment without Cause and you shall be entitled to the Accrued Obligations described in Section 7 and the benefits described in Section 8.

  

	 	(d)	For Cause. The Company may terminate your employment for “Cause,” and you shall be entitled to the Accrued Obligations described in Section 7. “Cause” shall mean, for purposes of this
letter, “cause” shall be defined as (1) conviction of any felony or indictable offense (other than one related to a vehicular offense) or other criminal act involving fraud; (2) willful misconduct that results in a material
economic detriment to the Company; (3) material violation of Company policies and directives, which is not cured after written notice and an opportunity for cure; (4) continued refusal by you to perform your duties after written notice
identifying the deficiencies and an opportunity for cure; and (5) a material violation by you of any material covenants to the Company. No action or inaction shall be deemed willful if not demonstrably willful and if taken or not taken by you
in good faith and with the understanding that such action or inaction was not adverse to the best interests of the Company. Reference in this paragraph to the Company shall also include direct and indirect subsidiaries of the Company, and
materiality shall be measured based on the action or inaction and the impact upon the Company taken as a whole. The Company may suspend you from employment (without pay, and without vesting credit for outstanding equity awards) upon your indictment
for the commission of a felony or indictable offense as described under clause (1) above. Such suspension may remain effective until such time as there has been a final adjudication with respect to the offense in question. If such final
adjudication does not result in a conviction, as soon as practicable following such final adjudication, the Company will pay you the base salary and target bonus amount that you would have received for the period during which you were suspended
without pay (with interest from the date such amounts would otherwise have been paid at the short-term applicable federal rate, compounded semi-annually, as determined under Section 1274 of the Internal Revenue Code of 1986, as amended, for the
month in which payment would have been made but for the delay) and you will receive vesting credit for purposes of your outstanding equity awards. 

 Brian Stolz 
 Page 5

  

	 	(e)	For Good Reason. You may terminate your employment for Good Reason (as defined below) by delivering to the Company a Notice of Termination (as defined below) not less than thirty (30) days prior to the
termination of your employment for Good Reason and you shall be entitled to the Accrued Obligations described in Section 7 and the benefits described in Section 8. The Company shall have the option of terminating your duties and
responsibilities prior to the expiration of such thirty-day notice period. For purposes of this letter, Good Reason shall mean the occurrence of any of the events or conditions described in clauses (i) through (iii) immediately below which
are not cured by the Company (if curable) within thirty (30) days after the Company has received written notice from you which notice must be provided by you within ninety (90) days of the initial existence of the event or condition
constituting Good Reason specifying the particular events or conditions which constitute Good Reason and the specific cure requested by you. For the avoidance of doubt, the provisions of this Section 6(e) shall not be triggered upon any event
or circumstance resulting from any change in duties or responsibilities (including any corresponding title change) so long as your title is at the level of senior vice president (or a comparable title) or above; your death or Disability; the
termination of your employment for Cause; or your termination of your employment other than for Good Reason. 

  

	 	(i)	Diminution of Responsibility. your ceasing to have a position at the level of senior vice president (or a comparable title) or above with respect to one or more businesses; 

 

	 	(ii)	Compensation Reduction. Any reduction in your base salary or target bonus opportunity which is not comparable to reductions in the base salary or target bonus opportunity of all other similarly-situated employees
at the Company; or 

  

	 	(iii)	Company Breach. Any other material breach by the Company of any material provision of this letter. 

  

	 	(f)	Upon or Following Expiration of Employment Term. For the avoidance of doubt, no payments shall be due to you under this letter agreement upon a termination of your employment for any or no reason upon the
expiration of, or at any time following, the Employment Term. 

  

	 	(g)	Notice of Termination. With the exception of a termination described in Section 6(a), any termination of your employment by the Company or by you shall be communicated by written Notice of Termination to the
other party hereto. For purposes of this letter agreement, a “Notice of Termination” shall mean a notice which indicates a termination date, the specific termination provision in this letter agreement relied upon and sets forth in
reasonable detail the facts and circumstances claimed to provide a basis for termination of your employment under the provision so indicated. For purposes of this letter agreement, no such termination of your employment hereunder shall be effective
without such Notice of Termination (unless waived by the party entitled to receive such notice). 

 Brian Stolz 
 Page 6

  

	7.	Accrued Obligations. Upon any termination of your employment during the Employment Term, you will be entitled to (i) payment of the earned and unpaid base salary and accrued and unpaid vacation time
through the date of termination; (ii) reimbursement, within sixty (60) days following submission by you to the Company of appropriate supporting documentation, for any unreimbursed business expenses properly incurred by you in accordance
with Company policy prior to the date of your termination; provided claims for such reimbursement (accompanied by appropriate supporting documentation) are submitted to the Company within ninety (90) days following the date of your termination
of employment; and (iii) such employee benefits, if any, to which you are entitled under the employee benefit plans of the Company under the terms of such plans (the amounts described in clauses (i) through (iii) hereof being referred
to as the “Accrued Obligations”). The treatment of any deferred compensation or equity or equity-based award held by you upon termination shall be governed by the terms of the applicable plan and/or agreement (as modified by this letter
agreement, if applicable). 

  

	8.	Severance Benefits. If your employment is terminated by the Company without Cause or by you for Good Reason, the Company shall have the following obligations: 

 

	 	(a)	The Company will pay you an amount equal to the sum of (A) your annual salary as of the Termination Date, plus (B) your annual target bonus as of the Termination Date, provided that, if your termination occurs
either in contemplation of a Change in Control or at any time within twelve (12) months following a Change in Control, the Company shall instead pay you an amount equal to two times the sum of (A) your annual salary as of the Termination
Date, plus (B) your annual target bonus as of the Termination Date. 

  

	 	(b)	In addition, the Company will pay you any bonus earned but unpaid in respect of any fiscal year preceding the Termination Date. The Company will also pay you a bonus in respect of the fiscal year in which the
Termination Date occurs, as though you had continued in employment until the payment of bonuses by the Company to its senior management for such fiscal year, in an amount equal to the product of (A) the lesser of (x) the bonus that you
would have been entitled to receive based on actual achievement against the stated performance objectives or (y) the bonus that you would have been entitled to receive assuming that the applicable performance objectives for such fiscal year
were achieved at “target”, and (B) a fraction (i) the numerator of which is the number of days in such fiscal year through Termination Date and (ii) the denominator of which is 365; provided that, if your termination occurs
at any time within twelve (12) months following a Change in Control (or during the six months prior to a Change in Control if such termination was in contemplation of, and directly related to, the Change in Control), then in the foregoing
calculation the amount under (A) shall be equal to (y). Any bonus payable to you under this Section 8(b) shall be paid in no event later than March 15 of the calendar year following the calendar year in which the Termination Date
occurs. 

 Brian Stolz 
 Page 7

  

	 	(c)	The Company will provide you (and your dependents) with continued coverage under any health, medical, dental or vision program or policy in which you were eligible to participate at the time of your employment
termination for 12 months following such termination on payment terms no less favorable to you and your dependents (including with respect to payment for the costs thereof) than those in effect immediately prior to such termination (it being
understood that such programs or policies shall remain subject to change from time to time); 

  

	 	(d)	The Company shall provide outplacement services through one or more outside firms of your choosing up to an aggregate of $20,000, which services shall extend until the earlier of (i) 12 months following the
termination of your employment or (ii) the date that you secure full time employment. 

  

	 	(e)	Notwithstanding anything herein to the contrary, the Company shall have no obligation to pay or provide any of the severance benefits provided for by Section 8 of this letter agreement and shall have no obligations
to you in respect of the termination of your employment save and except for obligations that are expressly established by applicable employment standards legislation unless you execute and deliver, within 60 days of the date of your termination, and
do not revoke, a general release in a form reasonably satisfactory to the Company and any revocation period set forth in the release has lapsed. Subject to the provisions of Section 11(b), the Company shall pay all cash severance benefits due
within 10 business days following the satisfaction of all of the conditions set forth in the preceding sentence. You shall not be required to mitigate the amount of any severance payment provided for under this letter by seeking other employment or
otherwise and no such payment shall be offset or reduced by the amount of any compensation or benefits provided to you in any subsequent employment, except that the benefit continuation described in Section 8(c) may be reduced by the Company to
the extent that you obtain replacement coverage following the Date of Termination. 

  

	 	(f)	Notwithstanding anything herein to the contrary, in no event shall the timing of your execution of the general release, directly or indirectly, result in you designating the calendar year of payment, and if a payment
that is subject to execution of the general release could be made in more than one taxable year, payment shall be made in the later taxable year. 

  

	9.	Change in Control. For purposes of each equity award outstanding as of the date hereof, (notwithstanding anything to the contrary in the applicable award agreement), a “Change in Control” shall
be deemed to occur if and when the first of the following occurs: 

  

	 	(a)	the acquisition (other than from the Company), by any person (as such term is defined in Section 13(c) or 14(d) of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”)) of beneficial
ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of fifty percent (50%) or more of the combined voting power of the Company’s then outstanding voting securities; 

 Brian Stolz 
 Page 8

  

	 	(b)	the individuals who, as of the date hereof, are members of the Board (the “Incumbent Board”), cease for any reason to constitute at least a majority of the Board, unless the election, or nomination for
election by the Company’s shareholders, of any new director was approved by a vote of at least a majority of the Incumbent Board, and such new director shall be considered as a member of the Incumbent Board; 

 

	 	(c)	the closing of an amalgamation or similar business combination (each, an “Amalgamation”) involving the Company if (i) the shareholders of the Company, immediately before such Amalgamation, do not, as a
result of such Amalgamation, own, directly or indirectly, more than fifty percent (50%) of the combined voting power of the then outstanding voting securities of the entity resulting from such Amalgamation in substantially the same proportion
as their ownership of the combined voting power of the voting securities of the Company outstanding immediately before such Amalgamation or (ii) immediately following the Amalgamation, the individuals who comprised the Board immediately prior
thereto do not constitute at least a majority of the board of directors of the entity resulting from such Amalgamation (or, if the entity resulting from such Amalgamation is then a subsidiary, the ultimate parent thereof); 

 

	 	(d)	a complete liquidation or dissolution of the Company or the closing of an agreement for the sale or other disposition of all or substantially all of the assets of the Company. 

Notwithstanding the foregoing, a Change in Control shall not be deemed to occur solely because fifty percent (50%) or more of the
combined voting power of the Company’s then outstanding securities is acquired by (i) a trustee or other fiduciary holding securities under one or more employee benefit plans maintained by the Company or any of its subsidiaries or
(ii) any corporation which, immediately prior to such acquisition, is owned directly or indirectly by the shareholders of the Company in the same proportion as their ownership of shares in the Company immediately prior to such acquisition. In
addition, notwithstanding the foregoing, solely to the extent required by Section 409A of the Internal Revenue Code of 1986 (“Section 409A”), a Change of Control shall be deemed to have occurred only if a change in the ownership or
effective control of the Company or a change in ownership of a substantial portion of the assets of the Company shall also be deemed to have occurred under Section 409A. 
  

	10.	Covenant Not to Solicit. 

  

	 	(a)	Covenant. To protect the confidential information and other trade secrets of the Company and its affiliates, you agree, during your employment with the Company or any of its affiliates and for a period of twelve
(12) months after your cessation of employment with the Company or any of its affiliates, not to solicit, attempt to solicit, or participate in or assist in any way in the solicitation or attempted solicitation of any employees or independent
contractors of the Company or any its affiliates. For purposes of this covenant, “solicit” or “solicitation” means directly or indirectly influencing or attempting to influence employees of the Company or any of its affiliates to
become employed with any other person, partnership, firm, corporation or other entity. You agree that the covenants contained in this paragraph are reasonable and necessary to protect the confidential information and other trade secrets of the
Company and its affiliates, provided, that solicitation through general advertising or the provision of references shall not constitute a breach of such obligations. 

 Brian Stolz 
 Page 9

  

	 	(b)	Remedies for Breach of Obligations Under the Covenants Not to Solicit Above. It is the intent and desire of you and the Company (and its affiliates) that the restrictive provisions of Section 10(a) above be
enforced to the fullest extent permissible under the laws and public policies as applied in each jurisdiction in which enforcement is sought. If any particular provision in such paragraph shall be determined to be invalid or unenforceable, such
covenant shall be amended, without any action on the part of either party hereto, to delete therefrom the portion so determined to be invalid or unenforceable, such deletion to apply only with respect to the operation of such covenant in the
particular jurisdiction in which such adjudication is made. Your obligations under Section 10(a) shall survive the termination of your employment with or any other employment arrangement with the Company or any of its affiliates. You
acknowledge that the Company or its affiliates will suffer irreparable injury, not readily susceptible of valuation in monetary damages, if you breach your obligations under Section 10(a). Accordingly, you agree that the Company and its
affiliates will be entitled, in addition to any other available remedies, to obtain injunctive relief against any breach or prospective breach by you of your obligations under Section 10(a) in any Federal or state court sitting in the State of
New Jersey, or, at the Company’s (or its affiliate’s) election, in any other state or jurisdiction in which you maintain your principal residence or your principal place of business. You agree that the Company or its affiliates may seek
the remedies described in the preceding sentence notwithstanding any arbitration or mediation agreement that you may enter into with the Company or any of its affiliates. You hereby submit to the non-exclusive jurisdiction of all those courts for
the purposes of any actions or proceedings instituted by the Company or its affiliates to obtain that injunctive relief, and you agree that process in any or all of those actions or proceedings may be served by registered mail, addressed to the last
address provided by you to the Company or its affiliates, or in any other manner authorized by law. 

  

	11.	Miscellaneous. 

  

	 	(a)	Indemnification. You shall be indemnified by the Company as provided in its articles or, if applicable, pursuant to an indemnification agreement with the Company if such agreements are provided to
similarly-situated employees. 

  

	 	(b)	Section 409A. The parties intend for the payments and benefits under this letter agreement to be exempt from Section 409A or, if not so exempt, to be paid or provided in a manner which complies with the
requirements of such section, and intend that this letter agreement shall be construed and administered in accordance with such intention. Any payments that qualify for the “short-term deferral” exception or another exception under
Section 409A shall be paid under the applicable exception. For purposes of the limitations on nonqualified deferred compensation under Section 409A, each payment of compensation under this letter agreement shall be treated as a separate
payment of compensation. Notwithstanding anything contained herein to the contrary, to the extent required in order to avoid accelerated taxation and/or tax penalties under Section 409A, amounts that would otherwise be payable and benefits that
would otherwise be provided pursuant to this letter during the six-month period immediately following your separation from service shall instead be paid on the first business day after the date that is six months following your Termination Date (or
death, if earlier), with interest from the date such amounts would otherwise have been paid at the short-term applicable federal rate, compounded semi-annually, as determined under Section 1274 of the Internal Revenue Code of 1986, as amended,
for the month in which payment would have been made but for the delay in payment required to avoid the imposition of an additional rate of tax on you under Section 409A. With respect to reimbursements from the Company to which you are entitled
(pursuant to Section 5(b) or otherwise) (i) the amount of reimbursements (or in-kind benefits) to which you may become entitled in any one calendar year shall not affect the amount of expenses eligible for reimbursement (or in-kind
benefits) hereunder in any other calendar year; (ii) each reimbursement to which you become entitled shall be made by the Company as soon as administratively practicable following your submission of the supporting documentation, but in no event
later than the close of business of the calendar year following the calendar year in which the reimbursable expense is incurred and (iii) your right to reimbursement (or in-kind benefits) cannot be liquidated or exchanged for any other benefit
or payment. 

 Brian Stolz 
 Page
10 
  

	 	(c)	Recovery of Incentive Compensation. You acknowledge and agree that incentive compensation granted to you following the Effective Date relating to your employment with the Company shall be subject to the terms of
the Company’s policies on the recovery of incentive cash compensation (sometimes referred to as “clawback”) as in effect from time to time; provided that all of your incentive compensation, whenever granted, shall be subject to such
additional clawback provisions as required by law and applicable listing rules. 

  

	 	(d)	Withholding. The Company shall be entitled to withhold the amount, if any, of all taxes of any applicable jurisdiction required to be withheld by an employer with respect to any amount paid to you hereunder. The
Company, in its sole and absolute discretion, shall make all determinations as to whether it is obligated to withhold any taxes hereunder and the amount hereof. 

  

	 	(e)	Modification. No provision of this letter agreement may be modified, waived or discharged unless such waiver, modification or discharge is agreed to in writing and signed by you and the Company. No waiver by
either party hereto at any time of any breach by the other party hereto of, or compliance with, any condition or provision of this letter agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or
conditions at the same or at any prior or subsequent time. No agreement or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by any party which are not expressly set forth in this letter
agreement. 

 Brian Stolz 
 Page
11 
  

	 	(f)	Assignment. This letter agreement, and all of your rights and duties hereunder, shall not be assignable or delegable by you. This letter agreement may be assigned by the Company to a person or entity which is an
affiliate or a successor in interest to substantially all of the assets or business operations of the Company. Upon such assignment, the rights and obligations of the Company hereunder shall become the rights and obligations of such affiliate or
successor person or entity. 

  

	 	(g)	Notice. For the purposes of this letter agreement, notices and all other communications provided for in the letter agreement (including the Notice of Termination) shall be in writing and shall be deemed to have
been duly given when personally delivered or sent by certified mail, return receipt requested, postage prepaid, addressed to the respective addresses last given by each party to each other party; provided that all notices to you shall be directed to
you at your primary home address on file with the Company; and provided that all notices to the Company shall be directed to the attention of the Chief Executive Officer of the Company with a copy to the General Counsel. All notices and
communications shall be deemed to have been received on the date of delivery thereof or on the third business day after the mailing thereof, except that notice of change of address shall be effective only upon receipt. 

 

	 	(h)	Counterparts. This letter agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

  

	 	(i)	Governing Law. This letter agreement is governed by the laws of the State of New Jersey. 

  

	 	(j)	Currency. All currency amounts set forth in the letter agreement refer to U.S. dollars. 

  

	 	(k)	Policies. You acknowledge and agree that the policies of the Company as in effect from time to time will govern any other matter not specifically covered by this letter agreement. Without limiting the foregoing,
you agree that during your employment by the Company, you will not engage in any activities that constitute a conflict of interest with the interests of the Company, as outlined in the Company’s conflict of interest policies for employees in
effect from time to time. 

 Brian Stolz 
 Page
12 
  

	 	(l)	No Good Reason Trigger. You acknowledge and agree that your transition from the roles of Executive Vice President of Administration and Chief Human Capital Officer, and from your designation as a member of the
EMT and a Section 16 executive officer or other executive officer, to the role of Senior Vice President – Neurology, Dentistry and Generics and, if applicable, to a member of the E-EMT (it being understood that there is no obligation to
create an E-EMT and you shall have no right or remedy should the Company not create, or later dissolve, the E-EMT), including the resulting change in duties, responsibilities, and title, will not constitute “Good Reason” within the meaning
of the June 2011 Letter, any Valeant equity awards that you hold, or any other compensation plan or arrangement of Valeant and its affiliates, and that any future “Good Reason” trigger shall be governed only by the terms and provisions
(including the definition of “Good Reason”) as set forth in this letter agreement. 

 As confirmation of acceptance of this
employment offer, please sign this letter agreement indicating your agreement and acceptance of the terms and conditions of employment. In addition, please mail the original signed letter agreement in the envelope provided. A duplicate copy
of this letter agreement is included for your records. 
  

			
	Sincerely,
	
	Valeant Pharmaceuticals International, Inc.
		
	By:	 	/s/ J. Michael Pearson
		 	 J. Michael Pearson
 Chief Executive
Officer

  

	
	
	/s/ Brian Stolz
	 Brian StolzEX-10.27

 Exhibit 10.27 
  

 
 CONFIDENTIAL 

April 25, 2015 
 Ms. Anne Whitaker 

Dear Anne: 
 This letter outlines the details of your employment
with Valeant Pharmaceuticals International, Inc. or its applicable subsidiary (the “Company”), and your Company assignment. The date your employment commences is referred to herein as the “Commencement Date.” 

 

	 	•	 	Title: Executive Vice President, Group Company Chairman, reporting to the Chief Executive Officer. 

  

	 	•	 	Office Location: Your principal place of employment will be in New Jersey. 

  

	 	•	 	Base Salary and Commencement Date: Your base salary will be $50,000 per month ($600,000 annualized). Your Commencement Date shall be a date mutually agreed between you and the Company, provided that such
date shall be no later than May 31, 2015. 

  

	 	•	 	Sign-on Bonus. The Company will pay you a one-time sign-on bonus payment of $900,000, which amount shall be paid to you promptly following the Commencement Date, subject to your continued employment on the
payment date. In the event that you terminate your employment other than for Good Reason or should the Company terminate your employment for Cause, in either case within 2 years of the Commencement Date, you will immediately repay to the Company a
pro-rata portion of the net amount of the sign-on bonus payment actually received by you after tax and other applicable withholdings, based on the portion of such 2 year period which has not elapsed as of the date of termination. 

 

	 	•	 	Annual Incentive: You will be eligible to participate in the Company’s management bonus plan beginning with the 2015 calendar year, on a pro-rata basis for the portion of 2015 during which you are
employed. Your target bonus will be 80% of your base salary, with the potential of up to 160% of your base salary. This plan, and therefore your participation, is subject to change at the discretion of the Board of Directors. Bonuses are payable at
the time the other management bonuses are paid. To be eligible for any bonus payment, you must be employed by the Company, and you must not have given or received notice of the termination of your employment, on the day on which the applicable bonus
is paid to other members of the Company management. 

 Ms. Anne Whitaker 

April 25, 2015 
 Page 2 of 10 

CONFIDENTIAL 
  

	 	•	 	Equity Award: The Company will recommend to the Talent and Compensation Committee of the Company’s Board of Directors (the “Committee”) the following equity award, valued at approximately
$8,000,000: 

 Performance Share Units (each a “PSU”), which vest between 0-300%, based on meeting certain company
performance criteria, as measured by total shareholder return approximately three years from the grant date. The triggers for 1x, 2x and 3x vesting shall be based on the Company’s shares attaining a 10%, 20% and 30% 3-year compound annual
growth rate, respectively, with measurements governed by the award agreement. 
 This equity award is contingent upon your acceptance of
this letter agreement and the approval of the Committee and will be made pursuant to the terms of the Company’s 2014 Omnibus Incentive Plan and governed by such plan and applicable grant agreements. The grant date for the equity award set forth
above shall be on the date that is the later of the Commencement Date and the date that the Committee approves such award. 
 The PSUs shall
have a base price (from which total shareholder return is measured) equal to the 20-trading-day average of the Company’s closing share price on the NYSE prior to the grant date. 

 

	 	•	 	Share Ownership Commitment. You also agree to comply with any share ownership requirements adopted by the Company applicable to you, which shall be on the same terms as similarly situated executives of the
Company. 

  

	 	•	 	Matching Grants for Share Purchases. In connection with such share ownership, you shall also be eligible to receive matching share units under the Company’s matching share unit program in accordance
with its terms generally applicable to similarly situated executives of the Company, which currently provide for you to receive a grant of one matching share unit for each common share of the Company purchased, up to an amount equal to the two times
the sum of your annual base salary and target bonus. Each such matching share unit shall vest in equal annual portions over the 3-year period following grant and shall have such other terms consistent with the terms customarily provided to similarly
situated executives of the Company. 

  

	 	•	 	Good Reason. You may terminate your employment for Good Reason (as defined below) by delivering to the Company a Notice of Termination (as defined below) not less than thirty (30) days prior to the
termination of your employment for Good Reason. The Company shall have the option of terminating your duties and responsibilities prior to the expiration of such thirty-day notice period, subject to the payment by the Company of the compensation and
benefits provided in this letter, as may be applicable. For purposes of this letter, “Good Reason” shall mean the occurrence of any of the events or conditions described in clauses (i) through (iii) immediately below which are
not cured by the Company (if susceptible to cure by the Company) within thirty (30) days after the Company has received a “Notice of Termination.” “Notice of Termination” means a written notice provided by you within ninety
(90) days of the initial existence of the event or condition constituting Good Reason specifying the particular events or conditions which constitute Good Reason and the specific cure requested by you. 

 Ms. Anne Whitaker 

April 25, 2015 
 Page 3 of 10 

CONFIDENTIAL 
  

	 	(i)	Diminution of Responsibility. (A) any material reduction in your duties or responsibilities as in effect immediately prior thereto, or (B) removal of you from the position of Executive Vice President, Group
Company Chairman. For the avoidance of doubt, the term “Diminution of Responsibility” shall not include (Y) any such removal resulting from a promotion, your death or Disability, the termination of your employment for Cause, or your
termination of your employment other than for Good Reason, (Z) the reduction of or change in any particular duties or responsibilities provided you are given other duties or responsibilities such that your overall duties and responsibilities
remain at least substantially comparable to your overall duties and responsibilities prior to the reduction or change; 

  

	 	(ii)	Compensation Reduction. Any reduction in your base salary or target bonus opportunity which is not comparable to reductions in the base salary or target bonus opportunity of other similarly-situated senior executives at
the Company; or 

  

	 	(iii)	Company Breach. Any other material breach by the Company of any material provision of this letter. 

  

	 	•	 	Change in Control. For purposes of this letter and, except to the extent as would result in a violation of Section 409A of the Code, a “Change in Control” shall be deemed to occur if and
when the first of the following occurs: 

  

	 	(i)	the acquisition (other than from the Company), by any person (as such term is defined in Section 13(c) or 14(d) of the Securities Exchange Act of 1934, as amended (the “1934 Act”)) of beneficial ownership
(within the meaning of Rule 13d-3 promulgated under the 1934 Act) of fifty percent (50%) or more of the combined voting power of the Company’s then outstanding voting securities; 

 

	 	(ii)	the individuals who, as of the date hereof, are members of the Board (the “Incumbent Board”), cease for any reason to constitute at least a majority of the Board, unless the election, or nomination for
election by the Company’s shareholders, of any new director was approved by a vote of at least a majority of the Incumbent Board, and such new director shall, for purposes of this letter, be considered as a member of the Incumbent Board;

 Ms. Anne Whitaker 

April 25, 2015 
 Page 4 of 10 

CONFIDENTIAL 
  

	 	(iii)	the closing of an amalgamation or similar business combination (each, an “Amalgamation”) involving the Company if (i) the shareholders of the Company, immediately before such Amalgamation, do not, as a
result of such Amalgamation, own, directly or indirectly, more than fifty percent (50%) of the combined voting power of the then outstanding voting securities of the entity resulting from such Amalgamation in substantially the same proportion
as their ownership of the combined voting power of the voting securities of the Company outstanding immediately before such Amalgamation or (ii) immediately following the Amalgamation, the individuals who comprised the Board immediately prior
thereto do not constitute at least a majority of the board of directors of the entity resulting from such Amalgamation (or, if the entity resulting from such Amalgamation is then a subsidiary, the ultimate parent thereof); or 

 

	 	(iv)	a complete liquidation or dissolution of the Company or the closing of an agreement for the sale or other disposition of all or substantially all of the assets of the Company. 

Notwithstanding the foregoing, a Change in Control shall not be deemed to occur pursuant to this letter agreement, solely because fifty
percent (50%) or more of the combined voting power of the Company’s then outstanding securities is acquired by (i) a trustee or other fiduciary holding securities under one or more employee benefit plans maintained by the Company or
any of its subsidiaries or (ii) any corporation which, immediately prior to such acquisition, is owned directly or indirectly by the shareholders of the Company in the same proportion as their ownership of shares in the Company immediately
prior to such acquisition. In addition, notwithstanding the foregoing, solely to the extent required by Section 409A, a Change of Control shall be deemed to have occurred only if a change in the ownership or effective control of the Company or
a change in ownership of a substantial portion of the assets of the Company shall also be deemed to have occurred under Section 409A. 
  

	 	•	 	Disability. The Company may terminate your employment, on written notice to you after having established your Disability and while you remain Disabled, subject to the payment by the Company to you of the
applicable compensation and benefits provided pursuant to this letter agreement. For purposes of this letter agreement, “Disability” shall have the meaning assigned to such term in the 2014 Omnibus Incentive Plan. 

 
  

	 	•	 	Cause. The Company may terminate your employment for “Cause”, subject to the payment by the Company to you of the applicable compensation and benefits provided in this letter agreement.
“Cause” shall mean, for purposes of this letter, “cause” as defined by applicable common law and (1) conviction of any felony or indictable offense (other than one related to a vehicular offense) or other criminal act
involving fraud; (2) willful misconduct that results in a material economic detriment to the Company; (3) material violation of Company policies and directives, which is not cured after written notice and a reasonable opportunity for cure;
(4) continued refusal by you to perform your duties after written notice identifying the deficiencies and a reasonable opportunity for cure; or (5) a material violation by you of any material covenants to the Company. No action or inaction
shall be, or be deemed to be, willful if not demonstrably willful and if taken or not taken by you in good faith and with the understanding that such action or inaction was not adverse to the best interests of the Company. Reference in this
paragraph to the Company shall also include direct and indirect subsidiaries of the Company, and materiality shall be measured based on the action or inaction and the impact upon the Company taken as a whole. The Company may suspend you, with pay,
upon your indictment for the commission of a felony or indictable offense as described under clause (1) above. Such suspension may remain effective until such time as the indictment is either dismissed or a verdict of not guilty has been
entered. 

 Ms. Anne Whitaker 

April 25, 2015 
 Page 5 of 10 

CONFIDENTIAL 
  

	 	•	 	Employee and Executive Benefits. You will be eligible to participate in the employee benefit plans and programs generally made available to similarly situated employees of the Company on the terms and
conditions applicable generally to all employees. In addition, the Company shall reimburse you for incremental taxes incurred by you outside of the United States because of any services you provide to the Company outside of the United States or
any business that the Company conducts outside of the United States, if such incremental amount during any tax year exceeds 1% or more of your average base salary for such tax year. You shall be required to participate in any tax
equalization program the Company may have in effect from time to time in order to qualify for the benefit described in the preceding sentence. 

 

	 	•	 	Conditions to Reimbursement. The following provisions shall be in effect for any reimbursements (and in-kind benefits) to which you otherwise may become entitled under this letter, in order to assure that
such reimbursements (and in-kind benefits) do not create a deferred compensation arrangement subject to Section 409A of the Internal Revenue Code (“Section 409A”): 

 

	 	(i)	The amount of reimbursements (or in-kind benefits) to which you may become entitled in any one calendar year shall not affect the amount of expenses eligible for reimbursement (or in-kind benefits) hereunder in any
other calendar year. 

  

	 	(ii)	Each reimbursement to which you become entitled shall be made by the Company as soon as administratively practicable following your submission of the supporting documentation, but in no event later than the close of
business of the calendar year following the calendar year in which the reimbursable expense is incurred. 

 Ms. Anne Whitaker 

April 25, 2015 
 Page 6 of 10 

CONFIDENTIAL 
  

	 	(iii)	Your right to reimbursement (or in-kind benefits) cannot be liquidated or exchanged for any other benefit or payment. 

  

	 	•	 	At-Will Employment. Your employment with the Company is “at will”. This means that you or the Company have the option to terminate your employment at any time, with or without advance notice, and
with or without Cause or with or without Good Reason. This letter of employment does not constitute an express or implied agreement of continuing or long term employment. The at will nature of your employment can be altered only by a written
agreement specifying the altered status of your employment. Such written agreement must be signed by both you and the Chief Executive Officer. 

  

	 	•	 	Severance Benefits. Notwithstanding the immediately preceding bullet paragraph, if your employment is terminated by the Company without Cause or by you for Good Reason, the Company shall have the following
obligations: 

  

	 	(i)	The Company will pay you an amount equal to the sum of (A) your annual salary as of the Termination Date, plus (B) your annual target bonus as of the Termination Date, provided that, if your termination occurs
either in contemplation of a Change in Control or at any time within twelve (12) months following a Change in Control, the Company shall instead pay you an amount equal to two times the sum of (A) your annual salary as of the Termination
Date, plus (B) your annual target bonus as of the Termination Date. The “Termination Date” shall be the date specified as the effective date of the termination of your employment in any notice of termination of employment provided by
the Company to you or accepted by the Company in the event of your giving notice of the termination of your employment. 

  

	 	(ii)	The Company will pay you any accrued but unpaid salary or vacation pay and any deferred compensation. In addition, the Company will pay you any bonus earned but unpaid in respect of any fiscal year preceding the
Termination Date. The Company will also pay you a bonus in respect of the fiscal year in which the Termination Date occurs, as though you had continued in employment until the payment of bonuses by the Company to its executives for such fiscal year,
in an amount equal to the product of (A) the lesser of (x) the bonus that you would have been entitled to receive based on actual achievement against the stated performance objectives or (y) the bonus that you would have been entitled
to receive assuming that the applicable performance objectives for such fiscal year were achieved at “target”, and (B) a fraction (i) the numerator of which is the number of days in such fiscal year through Termination Date and
(ii) the denominator of which is 365; provided that, if your termination occurs either in contemplation of a Change in Control or at any time within twelve (12) months following a Change in Control, then in the foregoing calculation the
amount under (A) shall be equal to (y). Any bonus payable to you under this bullet shall be paid in no event later than March 15 of the calendar year following the calendar year in which the Termination Date occurs. 

 Ms. Anne Whitaker 

April 25, 2015 
 Page 7 of 10 

CONFIDENTIAL 
  
  

	 	(iii)	The Company will provide you with continued coverage under any health, medical, dental or vision program or policy in which you were eligible to participate at the time of your employment termination for 12 months
following such termination on terms no less favorable to you and your dependents (including with respect to payment for the costs thereof) than those in effect immediately prior to such termination. 

 

	 	(iv)	The Company shall provide outplacement services through one or more outside firms of your choosing up to an aggregate of $20,000, which services shall extend until the earlier of (i) 12 months following the
Termination Date or (ii) the date that you secure full time employment. 

 Notwithstanding anything herein to the
contrary, the Company shall have no obligation to pay or provide any of the severance benefits referenced or set forth in this letter and shall have no obligations to you in respect of the termination of your employment save and except for
obligations that are expressly established by applicable employment standards legislation unless you execute and deliver, within 45 days of the date of your termination, and do not revoke, a general release in form satisfactory to the Company and
any revocation period set forth in the release has lapsed. Subject to compliance with Section 409A, the Company shall pay all cash severance benefits due within 10 business days following the satisfaction of all of the conditions set forth in
the preceding sentence. You shall not be required to mitigate the amount of any severance payment provided for under this letter by seeking other employment or otherwise and no such payment shall be offset or reduced by the amount of any
compensation or benefits provided to you in any subsequent employment. 
 Notwithstanding anything herein to the contrary, in no event
shall the timing of your execution of the general release, directly or indirectly, result in you designating the calendar year of payment, and if a payment that is subject to execution of the general release could be made in more than one taxable
year, payment shall be made in the later taxable year. 
 It is understood that, during your employment by the Company, you will not engage
in any activities that constitute a conflict of interest with the interests of the Company, as outlined in the Company’s conflict of interest policies for employees and executives in effect from time to time. 

 

	 	•	 	Covenant Not to Solicit. To protect the confidential information and other trade secrets of the Company and its affiliates, you agree, during your employment with the Company or any of its affiliates and
for a period of twelve (12) months after your cessation of employment with the Company or any of its affiliates, not to solicit, attempt to solicit, or participate in or assist in any way in the solicitation or attempted solicitation of any
employees or independent contractors of the Company or any of its affiliates. For purposes of this covenant, “solicit” or “solicitation” means directly or indirectly influencing or attempting to influence employees of the Company
or any of its affiliates to become employed with any other person, partnership, firm, corporation or other entity. You agree that the covenants contained in this paragraph are reasonable and necessary to protect the confidential information and
other trade secrets of the Company and its affiliates, provided, that solicitation through general advertising or the provision of references shall not constitute a breach of such obligations. For purposes of this paragraph, an “affiliate”
shall mean any direct or indirect subsidiary of the Company or any joint venture or collaboration in which any such entity or the Company participates. 

 Ms. Anne Whitaker 

April 25, 2015 
 Page 8 of 10 

CONFIDENTIAL 
  

	 	•	 	Remedies for Breach of Obligations Under the Covenants Not to Solicit Above. It is the intent and desire of you and the Company (and its affiliates) that the restrictive provisions in the paragraph
captioned “Covenant Not to Solicit” above be enforced to the fullest extent permissible under the laws and public policies as applied in each jurisdiction in which enforcement is sought. If any particular provision in such paragraph shall
be determined to be invalid or unenforceable, such covenant shall be amended, without any action on the part of either party hereto, to delete therefrom the portion so determined to be invalid or unenforceable, such deletion to apply only with
respect to the operation of such covenant in the particular jurisdiction in which such adjudication is made. Your obligations under the two preceding paragraphs shall survive the termination of your employment with or any other employment
arrangement with the Company or any of its affiliates. You acknowledge that the Company or its affiliates will suffer irreparable injury, not readily susceptible of valuation in monetary damages, if you breach your obligations under the paragraph
captioned “Covenant Not to Solicit” above. Accordingly, you agree that the Company and its affiliates will be entitled, in addition to any other available remedies, to obtain injunctive relief against any breach or prospective breach by
you of your obligations under either such paragraph in any Federal or state court sitting in the State of New Jersey, or, at the Company’s (or its affiliate’s) election, in any other state or jurisdiction in which you maintain your
principal residence or your principal place of business. You agree that the Company or its affiliates may seek the remedies described in the preceding sentence notwithstanding any arbitration or mediation agreement that you may enter into with the
Company or any of its affiliates. You hereby submit to the non-exclusive jurisdiction of all those courts for the purposes of any actions or proceedings instituted by the Company or its affiliates to obtain that injunctive relief, and you agree that
process in any or all of those actions or proceedings may be served by registered mail, addressed to the last address provided by you to the Company or its affiliates, or in any other manner authorized by law. 

 

	 	•	 	Indemnification. You shall be indemnified by the Company as provided in its articles or, if applicable, pursuant to an indemnification agreement with the Company if such agreements are provided to
similarly situated executives. 

 Ms. Anne Whitaker 

April 25, 2015 
 Page 9 of 10 

CONFIDENTIAL 
  

	 	•	 	Section 409A. The parties intend for the payments and benefits under this letter to be exempt from Section 409A or, if not so exempt, to be paid or provided in a manner which complies with the
requirements of such section, and intend that this letter shall be construed and administered in accordance with such intention. Any payments that qualify for the “short-term deferral” exception or another exception under Section 409A
shall be paid under the applicable exception. For purposes of the limitations on nonqualified deferred compensation under Section 409A, each payment of compensation under this letter shall be treated as a separate payment of compensation.
Notwithstanding anything contained herein to the contrary, to the extent required in order to avoid accelerated taxation and/or tax penalties under Section 409A, amounts that would otherwise be payable and benefits that would otherwise be
provided pursuant to this letter during the six-month period immediately following your separation from service shall instead be paid on the first business day after the date that is six months following your Termination Date (or death, if earlier),
with interest from the date such amounts would otherwise have been paid at the short-term applicable federal rate, compounded semi-annually, as determined under Section 1274 of the Internal Revenue Code of 1986, as amended, for the month in
which payment would have been made but for the delay in payment required to avoid the imposition of an additional rate of tax on you under Section 409A. 

  

	 	•	 	Withholding Taxes. All payments to you or your beneficiary under this letter agreement shall be subject to withholding on account of federal, state and local taxes as required by law. 

You acknowledge that you have, reviewed, agreed, signed and returned the Company’s customary on-boarding documentation. 

Policies of the Company will govern any other matter not specifically covered by this letter. 

Except as specifically described in the following sentence, the terms of this letter constitute the entire agreement between the Company and you with respect
to the subject matter hereof, superseding all prior agreements and negotiations. This letter is governed by the laws of the State of New Jersey. All currency amounts set forth in the letter agreement refer to U.S. dollars. 

This letter and the documents referenced herein are the full, complete and exclusive agreement between you and the Company regarding all of the subjects
covered by this letter, and supersede in their entirety any other written or verbal agreement between you and the Company. 

 Ms. Anne Whitaker 

April 25, 2015 
 Page 10 of 10 

CONFIDENTIAL 
 As confirmation of acceptance of this letter
agreement, please sign this letter indicating your agreement and acceptance of the terms and conditions of employment. In addition, please mail the original signed letter in the envelope provided. A duplicate copy of this letter is included
for your records. 
  

			
	Sincerely,
	
	Valeant Pharmaceuticals International, Inc.
		
	By:	 	/s/ J. Michael Pearson
		 	 J. Michael Pearson
 Chief Executive
Officer

  

	
	
	 /s/ Anne Whitaker

	 Anne Whitaker

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}]]